Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model

Translational Stroke Research

Volumn 9, Issue 5, 2018, Pages 530-539

  Webb, Robin L ^a,b   Kaiser, Erin E ^b   Scoville, Shelley L ^a   Thompson, Tyler A ^a   Fatima, Sumbul ^c   Pandya, Chirayukumar ^c   Sriram, Karishma ^b   Swetenburg, Raymond L ^a   Vaibhav, Kumar ^c   Arbab, Ali S ^d   Baban, Babak ^c   Dhandapani, Krishnan M ^d   Hess, David C ^d   Hoda, M N ^c   Stice, Steven L ^a,b  

^a Aruna Biomedical   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c AUGUSTA UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Neural stem cell extracellular vesicles; Preclinical stroke model; Thromboembolic stroke

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EPISODIC MEMORY; EXOSOME; FOOT; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LESION VOLUME; MESENCHYMAL STEM CELL; MIDDLE AGED; MOTOR PERFORMANCE; MOUSE; NEURAL STEM CELL; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; STRENGTH; THROMBOEMBOLISM; WALKING; AGE; ANIMAL; BIOLOGICAL THERAPY; CELL MOTION; CEREBRAL ARTERY DISEASE; COMPLICATION; CONVALESCENCE; DIAGNOSTIC IMAGING; DISEASE MODEL; IMMOBILIZATION; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; REGULATORY T LYMPHOCYTE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TH17 CELL; TIME FACTOR;

LEUKOCYTE ANTIGEN;

AGE FACTORS; ANIMALS; ANTIGENS, CD; CELL MOVEMENT; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; EXTRACELLULAR VESICLES; HINDLIMB SUSPENSION; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MESENCHYMAL STROMAL CELLS; MICE; NEURAL STEM CELLS; PSYCHOMOTOR PERFORMANCE; RECOVERY OF FUNCTION; STROKE; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 85039547348     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-017-0599-2     Document Type: Article

References (58)

1. Cheng NT, Kim AS. Intravenous thrombolysis for acute ischemic stroke within 3 hours versus between 3 and 4.5 hours of symptom onset. Neurohospitalist. 2015;5(3):101–9. 10.1177/1941874415583116
2. Boyle K, Joundi RA, Aviv RI. An historical and contemporary review of endovascular therapy for acute ischemic stroke. Neurovasc Imaging. 2017;3(1):1. 10.1186/s40809-016-0025-2
3. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke. A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. 2007;115(20):e478–534. 10.1161/circulationaha.107.181486
4. Duncan PW, Zorowitz R, Bates B, Choi JY, Glasberg JJ, Graham GD, et al. Management of adult stroke rehabilitation care. A Clinical Practice Guideline. Stroke. 2005;36(9):e100–e43. 10.1161/01.str.0000180861.54180.ff
5. Kapral MK, Wang H, Mamdani M, Tu JV. Effect of socioeconomic status on treatment and mortality after stroke. Stroke. 2002;33(1):268–75. 10.1161/hs0102.101169
6. Mendis S. Stroke disability and rehabilitation of stroke: World Health Organization perspective. Int J Stroke. 2013;8(1):3–4. 10.1111/j.1747-4949.2012.00969.x
7. Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40(2):510–5. 10.1161/STROKEAHA.108.526863
8. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke. 2011;42(3):825–9. 10.1161/STROKEAHA.110.601914
9. Chopp M, Zhang ZG. Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases. Expert Opin Emerg Drugs. 2015;20(4):523–6. 10.1517/14728214.2015.1061993
10. Basso M, Bonetto V. Extracellular vesicles and a novel form of communication in the brain. Front Neurosci. 2016;10:127. 10.3389/fnins.2016.00127
11. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–83. 10.1083/jcb.201211138
12. Gimona M, Pachler K, Laner-Plamberger S, Schallmoser K, Rohde E. Manufacturing of human extracellular vesicle-based therapeutics for clinical use. Int J Mol Sci. 2017;18(6) 10.3390/ijms18061190
13. Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig A-K, Radtke S, et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med. 2015;4(10):1131–43. 10.5966/sctm.2015-0078
14. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33(11):1711–5. 10.1038/jcbfm.2013.152
15. Zhang Y, Chopp M, Zhang ZG, Katakowski M, Xin H, Qu C, et al. Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury. Neurochem Int. 2016; 10.1016/j.neuint.2016.08.003
16. Wiklander OPB, Nordin JZ, O’Loughlin A, Gustafsson Y, Corso G, Mäger I et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4. 10.3402/jev.v4.26316
17. Morel L, Regan M, Higashimori H, Ng SK, Esau C, Vidensky S, et al. Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem. 2013;288(10):7105–16. 10.1074/jbc.M112.410944
18. Couch Y, Akbar N, Davis S, Fischer R, Dickens AM, Neuhaus AA, et al. Inflammatory stroke extracellular vesicles induce macrophage activation. Stroke. 2017;48(8):2292–6. 10.1161/strokeaha.117.017236
19. Zhang ZG, Chopp M. Exosomes in stroke pathogenesis and therapy. J Clin Invest. 2016;126(4):1190–7. 10.1172/JCI81133
20. Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, et al. Applying extracellular vesicles based therapeutics in clinical trials—an ISEV position paper. J Extracell Vesicles. 2015;4(1):30087. 10.3402/jev.v4.30087
21. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28(4):970–3. 10.1038/leu.2014.41
22. Hoda MN, Fagan SC, Khan MB, Vaibhav K, Chaudhary A, Wang P, et al. A 2 × 2 factorial design for the combination therapy of minocycline and remote ischemic perconditioning: efficacy in a preclinical trial in murine thromboembolic stroke model. Exp Transl Stroke Med. 2014;6(1):10. 10.1186/2040-7378-6-10
23. Hoda MN, Li W, Ahmad A, Ogbi S, Zemskova MA, Johnson MH, et al. Sex-independent neuroprotection with minocycline after experimental thromboembolic stroke. Exp Transl Stroke Med. 2011;3(1):16. 10.1186/2040-7378-3-16
24. Shin S, Mitalipova M, Noggle S, Tibbitts D, Venable A, Rao R, et al. Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells. 2006;24(1):125–38. 10.1634/stemcells.2004-0150
25. Dhara SK, Hasneen K, Machacek DW, Boyd NL, Rao RR, Stice SL. Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures. Differentiation. 2008;76(5):454–64. 10.1111/j.1432-0436.2007.00256.x
26. Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng A. 2009;15(8):1897–907. 10.1089/ten.tea.2008.0351
27. Hwang DW, Choi H, Jang SC, Yoo MY, Park JY, Choi NE, et al. Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using (99m)Tc-HMPAO. Sci Rep. 2015;5(1):15636. 10.1038/srep15636
28. Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire C, Chen JW, et al. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014;8(1):483–94. 10.1021/nn404945r
29. Wiklander OP, Nordin JZ, O'Loughlin A, Gustafsson Y, Corso G, Mager I, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4(1):26316. 10.3402/jev.v4.26316
30. Yang T, Fogarty B, LaForge B, Aziz S, Pham T, Lai L, et al. Delivery of small interfering RNA to inhibit vascular endothelial growth factor in zebrafish using natural brain endothelia cell-secreted exosome nanovesicles for the treatment of brain cancer. AAPS J. 2017;19(2):475–86. 10.1208/s12248-016-0015-y
31. Saari H, Lazaro-Ibanez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220(Pt B):727–37. 10.1016/j.jconrel.2015.09.031
32. Paschon V, Takada SH, Ikebara JM, Sousa E, Raeisossadati R, Ulrich H, et al. Interplay between exosomes, microRNAs and toll-like receptors in brain disorders. Mol Neurobiol. 2016;53(3):2016–28. 10.1007/s12035-015-9142-1
33. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79. 10.1038/nri855
34. Xin H, Li Y, Liu Z, Wang X, Shang X, Cui Y, et al. MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles. Stem Cells. 2013;31(12):2737–46. 10.1002/stem.1409
35. Sorensen AL, Timoskainen S, West FD, Vekterud K, Boquest AC, Ahrlund-Richter L, et al. Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types. Stem Cells Dev. 2010;19(8):1257–66. 10.1089/scd.2009.0309
36. Klinker MW, Marklein RA, Lo Surdo JL, Wei CH, Bauer SR. Morphological features of IFN-gamma-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114(13):E2598–E607. 10.1073/pnas.1617933114
37. Grønberg NV, Johansen FF, Kristiansen U, Hasseldam H. Leukocyte infiltration in experimental stroke. J Neuroinflammation. 2013;10:115. 10.1186/1742-2094-10-115
38. Chen Y, Garcia GE, Huang W, Constantini S. The involvement of secondary neuronal damage in the development of neuropsychiatric disorders following brain insults. Front Neurol. 2014;5:22. 10.3389/fneur.2014.00022
39. Prinz M, Erny D, Hagemeyer N. Ontogeny and homeostasis of CNS myeloid cells. Nat Immunol. 2017;18(4):385–92. 10.1038/ni.3703
40. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17-producing [gamma][delta]T cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946–50. http://www.nature.com/nm/journal/v15/n8/suppinfo/nm.1999_S1.html
41. Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9(9):895–905. 10.1016/S1474-4422(10)70164-2
42. Lovblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42(2):164–70. 10.1002/ana.410420206
43. Schellinger PD, Jansen O, Fiebach JB, Hacke W, Sartor K. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30(4):765–8. 10.1161/01.STR.30.4.765
44. Otero-Ortega L, Gomez de Frutos MC, Laso-Garcia F, Rodriguez-Frutos B, Medina-Gutierrez E, Lopez JA, et al. Exosomes promote restoration after an experimental animal model of intracerebral hemorrhage. J Cereb Blood Flow Metab. 2017; 10.1177/0271678X17708917
45. Chopp M, Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 2002;1(2):92–100. 10.1016/S1474-4422(02)00040-6
46. Yin KJ, Hamblin M, Chen YE. Angiogenesis-regulating microRNAs and ischemic stroke. Curr Vasc Pharmacol. 2015;13(3):352–65. 10.2174/15701611113119990016
47. Teng H, Zhang ZG, Wang L, Zhang RL, Zhang L, Morris D, et al. Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. J Cereb Blood Flow Metab. 2008;28(4):764–71. 10.1038/sj.jcbfm.9600573
48. Zhang Y, Chopp M, Meng Y, Katakowski M, Xin H, Mahmood A, et al. Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury. J Neurosurg. 2015;122(4):856–67. 10.3171/2014.11.JNS14770
49. Otero-Ortega L, Laso-Garcia F, Gomez-de Frutos MD, Rodriguez-Frutos B, Pascual-Guerra J, Fuentes B, et al. White matter repair after extracellular vesicles administration in an experimental animal model of subcortical stroke. Sci Rep. 2017;7:44433. 10.1038/srep44433
50. Charrin S, Jouannet S, Boucheix C, Rubinstein E. Tetraspanins at a glance. J Cell Sci. 2014;127(17):3641–8. 10.1242/jcs.154906
51. Schaar KL, Brenneman MM, Savitz SI. Functional assessments in the rodent stroke model. Exp Transl Stroke Med. 2010;2(1):13. 10.1186/2040-7378-2-13
52. Xin H, Wang F, Li Y, QE L, Cheung WL, Zhang Y, et al. Secondary release of exosomes from astrocytes contributes to the increase in neural plasticity and improvement of functional recovery after stroke in rats treated with exosomes harvested from microRNA 133b-overexpressing multipotent mesenchymal stromal cells. Cell Transplant. 2017;26(2):243–57. 10.3727/096368916X693031
53. Blum S, Hebert AE, Dash PK. A role for the prefrontal cortex in recall of recent and remote memories. Neuroreport. 2006;17(3):341–4. 10.1097/01.wnr.0000201509.53750.bc
54. Halgren E, Babb TL, Crandall PH. Activity of human hippocampal formation and amygdala neurons during memory testing. Electroencephalogr Clin Neurophysiol. 1978;45(5):585–601. 10.1016/0013-4694(78)90159-1
55. Frankland PW, Bontempi B. The organization of recent and remote memories. Nat Rev Neurosci. 2005;6(2):119–30. 10.1038/nrn1607
56. Lockhart SN, Mayda AB, Roach AE, Fletcher E, Carmichael O, Maillard P, et al. Episodic memory function is associated with multiple measures of white matter integrity in cognitive aging. Front Hum Neurosci. 2012;6:56. 10.3389/fnhum.2012.00056
57. Tulving E, Markowitsch HJ. Episodic and declarative memory: role of the hippocampus. Hippocampus. 1998;8(3):198–204. 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G
58. Lundy-Ekman L. Neuroscience: fundamentals for rehabilitation. 4th ed. St. Louis: Elsevier; 2013